Japan Medical Dynamic MarketingJapan Medical Dynamic Marketing, INC.7600東証プライム精密機器FY ending Mar 2026, consolidated, J-GAAP

Japan Medical Dynamic Marketing revenue and profit

Out of every ¥100 of sales, about ¥2 is left as operating profit. Revenue changed -4.8% from the prior year, operating profit -63.1%.

Five-year trend

Revenue¥23.9B
FY ending Mar 2022: ¥19.2B¥19.2BFY ending Mar 2023: ¥21.3B¥21.3BFY ending Mar 2024: ¥23.2B¥23.2BFY ending Mar 2025: ¥25.1B¥25.1BFY ending Mar 2026: ¥23.9B¥23.9BFY22FY23FY24FY25FY26
Operating income¥574.2M
FY ending Mar 2022: ¥2.66B¥2.66BFY ending Mar 2023: ¥2.02B¥2.02BFY ending Mar 2024: ¥1.75B¥1.75BFY ending Mar 2025: ¥1.56B¥1.56BFY ending Mar 2026: ¥574.2M¥574.2MFY22FY23FY24FY25FY26
Operating margin2.4%
FY ending Mar 2022: 13.9%13.9%FY ending Mar 2023: 9.5%9.5%FY ending Mar 2024: 7.5%7.5%FY ending Mar 2025: 6.2%6.2%FY ending Mar 2026: 2.4%2.4%FY22FY23FY24FY25FY26

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin1.1%
Asset turnover0.69×
ROA0.8%
ROA0.8%
Financial leverage1.64×
ROE1.2%

Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.

Net margin1.1%
2022: 11.1%11.1%2023: 6.7%6.7%2024: 5.5%5.5%2026: 1.1%1.1%2223242526
Asset turnover0.69×
2022: 0.70×0.70×2023: 0.75×0.75×2024: 0.76×0.76×2026: 0.69×0.69×2223242526
ROA0.8%
2022: 7.8%7.8%2023: 5.0%5.0%2024: 4.2%4.2%2025: -1.4%-1.4%2026: 0.8%0.8%2223242526
Financial leverage1.64×
2022: 1.37×1.37×2023: 1.38×1.38×2024: 1.42×1.42×2026: 1.64×1.64×2223242526
ROE1.2%
2022: 10.7%10.7%2023: 6.9%6.9%2024: 5.9%5.9%2026: 1.2%1.2%2223242526
PeriodNet marginAsset turnoverROAFinancial leverageROE
202211.1%0.70×7.8%1.37×10.7%
20236.7%0.75×5.0%1.38×6.9%
20245.5%0.76×4.2%1.42×5.9%
2025——×-1.4%—×—
20261.1%0.69×0.8%1.64×1.2%

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

PPE ÷ revenue36.7%
2021: 44.5%44.5%2022: 40.5%40.5%2023: 36.3%36.3%2024: 35.9%35.9%2025: 31.6%31.6%2026: 36.7%36.7%212223242526
PPE ÷ total assets24.6%
2021: 29.6%29.6%2022: 28.4%28.4%2023: 26.3%26.3%2024: 26.4%26.4%2025: 23.6%23.6%2026: 24.6%24.6%212223242526

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Investment and working-capital efficiency

Track R&D investment and how long operating capital remains tied up before sales turn into cash.

R&D spending¥864M
2021: ¥466.7M¥466.7M2022: ¥485.6M¥485.6M2023: ¥662.9M¥662.9M2024: ¥874M¥874M2025: ¥959M¥959M2026: ¥864M¥864M212223242526
R&D / revenue3.6%
2021: 2.8%2.8%2022: 2.5%2.5%2023: 3.1%3.1%2024: 3.8%3.8%2025: 3.8%3.8%2026: 3.6%3.6%212223242526
Receivable days—
2021: 98d98d212223242526
Payable days52d
2021: 40d40d2022: 46d46d2023: 49d49d2024: 61d61d2025: 51d51d2026: 52d52d212223242526

R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.

Income statement (JPY millions)

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Revenue19,19321,30823,17825,11423,917
Cost of revenue6,2047,3158,4169,4679,775
Gross profit12,98913,99314,76215,64714,142
SG&A10,32711,96813,01514,09113,568
Operating income2,6622,0251,7471,556574
Pretax income2,7501,7701,637-342494
Income tax608334331127219
Net income attributable to owners2,1361,4241,272-462263
Operating margin13.9%9.5%7.5%6.2%2.4%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

Assets

Cash 9%
Property, plant and equipment 25%
1%
Other assets 65%

Funding

4%
Other liabilities 25%
Equity 71%

Each bar totals 100% of assets; other is the residual.

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Cash and equivalents¥2.59B¥2.8B¥2.32B¥3.18B¥3.11B
Total assets¥27.3B¥29.4B¥31.5B¥33.7B¥35.7B
Net assets¥21.5B¥23.3B¥25.6B¥24.7B¥25.4B
Share capital¥3B¥3B¥3B¥3B¥3B
Property, plant and equipment¥7.77B¥7.74B¥8.32B¥7.95B¥8.78B
Intangible assets excluding goodwill¥292M¥263M¥219.3M¥430.2M¥429.9M
Investment securities—¥66.8M———
Current assets¥18B¥20B¥21.6B¥23.9B¥24.9B
Current liabilities¥2.9B¥3.63B¥4.03B¥7.26B¥7.71B
Trade payables¥785.7M¥979.2M¥1.4B¥1.33B¥1.4B
Short-term borrowings¥557M¥1.05B¥1.16B¥3.14B¥4.89B
Long-term borrowings¥1.25B¥732.2M¥259.8M¥110M¥765.8M
Total liabilities¥5.85B¥6.14B¥5.88B¥8.93B¥10.3B
Non-controlling interests¥104.7M¥130.5M¥92.5M¥62.2M¥27.6M
Equity attributable to owners of parent¥20B¥21B¥22B¥21.2B¥21.1B
Retained earnings¥14.6B¥15.7B¥16.6B¥15.8B¥15.6B
Treasury stock-¥111.9M-¥202.7M-¥165.6M-¥165.6M-¥144.7M

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第54期(2025/04/01-2026/03/31)

    ID S100YCSL2026-06-18Open
  • EDINET (FSA Japan)

    訂正有価証券報告書-第53期(2024/04/01-2025/03/31)

    ID S100WFM12025-07-31Open
  • EDINET (FSA Japan)

    有価証券報告書-第52期(2023/04/01-2024/03/31)

    ID S100TQMY2024-06-25Open
  • EDINET (FSA Japan)

    有価証券報告書-第51期(2022/04/01-2023/03/31)

    ID S100R4TF2023-06-27Open
  • EDINET (FSA Japan)

    有価証券報告書-第50期(令和3年4月1日-令和4年3月31日)

    ID S100OHJI2022-06-28Open
  • EDINET (FSA Japan)

    有価証券報告書-第49期(令和2年4月1日-令和3年3月31日)

    ID S100LLJR2021-06-22Open

Extracted from XBRL: 51 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.